Paul Sumner Strumph, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

University Of North Carolina At Chapel Hill School Of Medicine - Chapel Hill NC
Rank: Dept Med / Peds
Years: 1994-2000

University Of North Carolina At Chapel Hill School Of Medicine - Chapel Hill NC
Rank: Dept Med / Peds
Years: 2000-2005

None Reported

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
New England Journal of Medicine
Volume: 377
Date: 12 2017
https://www.nejm.org/doi/full/10.1056/NEJMoa1708337

Sotagliflozin in Combination with Optimized Insulin Therapy in Adults with Type 1 Diabetes: The North American inTandem1 Study
Diabetes Care
Volume: 41
Date: 09 2018
https://care.diabetesjournals.org/content/diacare/41/9/1970.full.pdf

A1C and Hypoglycemia Reduction at 24 and 52 Weeks with Sotagliflozin in Combination with Insulin in Adults with Type 1 Diabetes: The European inTandem2 Study
Diabetes Care
Volume: 42
Date: 05 2019
https://care.diabetesjournals.org/content/diacare/42/5/919.full.pdf

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
Diabetes Care
Volume: 42
Date: 05 2019
https://care.diabetesjournals.org/content/diacare/42/5/919.full.pdf

Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial
Diabetes Obes Metab
Volume: 21
Date: 06 2019
https://dom-pubs.onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13825